Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ropivacaine for Postoperative Pain in Ovarian Cyst Surgery
NCT01142622Phase 3Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Apr 2010
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Morphine consumption at 24 hours. Started Apr 2010; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01142622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142622.